Leprosy-associated Chronic Wound Management Using Biomaterials

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Wound Healing Research

Background:

• Leprosy-cured individuals often suffer from chronic wounds and deformities, significantly impacting their quality of life and rehabilitation.
• Existing treatments for chronic wounds in this population have limited success, potentially due to physiological acclimatization to the wound state.
• A novel strategy is needed to promote healing by utilizing biomaterials that gradually modify the wound environment.

Purpose of the Study:

• To develop human amnion (Amn)-derived biomaterial scaffolds.
• To evaluate the efficacy of these scaffolds in healing chronic wounds among leprosy-cured, deformed persons (LCDPs).

Main Methods:

• A rapid enzymatic protocol was employed to generate biomaterial scaffolds from discarded human Amn.
• A clinical trial involving 26 LCDPs was conducted using the developed biomaterial.
• The wound-healing potential of the biomaterial was compared against standard treatment procedures.

Main Results:

• Biomaterial-based treatment demonstrated superior healing efficiency for chronic wounds in LCDPs compared to standard treatments.
• The study highlights the effectiveness of Amn-derived biomaterials in promoting wound closure.

Conclusions:

• Biomaterial-based treatment presents an affordable and effective alternative for managing leprosy-related chronic wounds.
• Successful wound healing requires consideration of both local wound conditions and systemic factors.
• Effective wound management is crucial for the successful rehabilitation and societal reintegration of leprosy-cured individuals.